Amiloride for Pharmacokinetics

"Patients aged between 18 and 30 years old are eligible to be included in this clinical trial."

"Currently, seven clinical trials are being conducted in relation to Amiloride. Of these studies, two are classified as Phase 3 while the remainder is taking place primarily Salt Lake City with an additional six sites participating globally."

"As of 11/1/2022, this particular clinical trial has concluded its recruitment process. The investigation was originally posted on 9/28/2020 and no longer requires participants. However, 39 medical trials concerning pharmacokinetics are currently recruiting patients as well as 7 Amiloride-related studies with open enrollment slots."

"Commonly used to regulate elevated blood pressure, amiloride has also been prescribed as a therapeutic measure for nephrolithiasis, congestive heart failure (CHF), and polyuria."

"Prospective participants of this study must demonstrate proficiency in pharmacokinetics and be between the ages 18 to 30. The number of people accepted is limited to 15 individuals."

"This clinical trial is now closed. It began recruitment on September 28th 2020 and the last update was posted November 1st 2022. If you are looking for other trials, there are currently 39 different studies searching for participants with pharmacokinetics experience, as well as 7 research studies actively accepting candidates to participate in experiments involving Amiloride."